Trends and Costs Associated With the Diagnosis and Treatment of Infantile Spasms: A 10-Year Multicenter Retrospective Review

Autor: Mindl M. Weingarten, Jon A. Cokley, Brady Moffett, Shannon DiCarlo, Sunita N. Misra

Publikováno v: J Pediatr Pharmacol Ther

OBJECTIVE Early treatment of infantile spasms (IS) may be imperative for improvement of neurodevelopmental outcomes. Existing studies have led to inconclusive recommendations with variation in treatment. Our objective was to determine the national av

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8dc49f8102ac5bdad6f62db0b7bc87c
https://pubmed.ncbi.nlm.nih.gov/35002556

ASSOCIATION OF FRACTURES WITH FUROSEMIDE THERAPY IN PEDIATRIC MEDICAID PATIENTS WITH CONGENITAL HEART DISEASE

Autor: Ji Haeng Heo, Keila N. Lopez, Brady Moffett, Karen L. Rascati

Publikováno v: Journal of the American College of Cardiology. 69:573

Background: Furosemide is a loop diuretic that may cause a loss of bone mineral density, and thus an increased incidence of bone fractures. Congenital heart disease (CHD) patients are often placed on furosemide. The purpose was to determine the assoc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::038510c6e5411a76506ce0b54f5757bb
https://doi.org/10.1016/s0735-1097(17)33962-1

Bioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tablets.

Autor: Moffett BS; Brady Moffett Consulting, Pearland, TX, USA., DiSanto AR; ARD Pharmaceutical Consulting, Inc., Gobles, MI, USA., Espinosa O; Bioanalytical Sciences, Worldwide Clinical Trials, Austin, TX, USA., Hou J; Bioanalytical Sciences, Worldwide Clinical Trials, Austin, TX, USA., Colabuono P; Silvergate Pharmaceuticals, Inc., Greenwood Village, CO, USA.

Publikováno v: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2014 Nov; Vol. 3 (6), pp. 493-8. Date of Electronic Publication: 2014 Jun 27.